<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35054108</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">413</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11020413</ELocationID><Abstract><AbstractText>This multicenter cohort study investigated the differences between coronavirus disease 2019 (COVID-19) related symptoms and post-COVID symptoms between male and female COVID-19 survivors. Clinical and hospitalization data were collected from hospital medical records in a sample of individuals recovered from COVID-19 at five public hospitals in Spain. A predefined list of post-COVID symptoms was systematically assessed, but patients were free to report any symptom. Anxiety/depressive levels and sleep quality were also assessed. Adjusted multivariate logistic regressions were used to identify the association of sex with post-COVID related-symptoms. A total of 1969 individuals (age: 61, SD: 16 years, 46.4% women) were assessed 8.4 months after discharge. No overall significant sex differences in COVID-19 onset symptoms at hospital admission were found. Post-COVID symptoms were present in up to 60% of hospitalized COVID-19 survivors eight months after the infection. The number of post-COVID symptoms was 2.25 for females and 1.5 for males. After adjusting by all variables, female sex was associated with &#x2265;3 post-COVID symptoms (adj OR 2.54, 95%CI 1.671-3.865, <i>p</i> &lt; 0.001), the presence of post-COVID fatigue (adj OR 1.514, 95%CI 1.040-2.205), dyspnea (rest: adj OR 1.428, 95%CI 1.081-1.886, exertion: adj OR 1.409, 95%CI 1.109-1.791), pain (adj OR 1.349, 95%CI 1.059-1.720), hair loss (adj OR 4.529, 95%CI 2.784-7.368), ocular problems (adj OR 1.981, 95%CI 1.185-3.312), depressive levels (adj OR 1.606, 95%CI 1.002-2.572) and worse sleep quality (adj OR 1.634, 95%CI 1.097-2.434). Female sex was a risk factor for the development of some long-term post-COVID symptoms including mood disorders. Healthcare systems should consider sex differences in the management of long haulers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNAP, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Guerrero</LastName><ForeName>Jos&#xe9; D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0001-9378-0285</Identifier><AffiliationInfo><Affiliation>Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de Val&#xe8;ncia (UV), 46100 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>&#xd3;scar J</ForeName><Initials>&#xd3;J</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de Val&#xe8;ncia (UV), 46100 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro-Pardo</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9355-2909</Identifier><AffiliationInfo><Affiliation>Department of Developmental and Educational Psychology, Universitat de Val&#xe8;ncia (UV), 46010 Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Mayordomo</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9343-8439</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital Universitario Cl&#xed;nico San Carlos, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuadrado</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Universitario Cl&#xed;nico San Carlos, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arias-Naval&#xf3;n</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5059-7667</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Universidad Alfonso X El Sabio, 28691 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cigar&#xe1;n-M&#xe9;ndez</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Barrera</LastName><ForeName>Valent&#xed;n</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CNAP, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Aalborg University Hospital, 9100 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NNF21OC0067235</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant><Grant><GrantID>The LONG-COVID-EXP-CM</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">female</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">sex</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35054108</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pii">jcm11020413</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grisold W., Moro E., Teresa Ferretti M., Hege Aamodt G.A., Lebedeva E.R., Carvalho V., Rakusa M., Vonck K., Aybeck S., Hassan Mansou A., et al. Gender issues during the times of COVID-19 pandemic. Eur. J. Neurol. 2021;28:e73&#x2013;e77. doi: 10.1111/ene.14815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14815</ArticleId><ArticleId IdType="pmc">PMC8239897</ArticleId><ArticleId IdType="pubmed">33751757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenham C., Smith J., Morgan R., Gender and COVID-19 Working Group COVID-19: The gendered impacts of the outbreak. Lancet. 2020;395:846&#x2013;848. doi: 10.1016/S0140-6736(20)30526-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30526-2</ArticleId><ArticleId IdType="pmc">PMC7124625</ArticleId><ArticleId IdType="pubmed">32151325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J.M., Bai P., He W., Wu F., Liu X.F., Han D.M., Liu S., Yang J.K. Gender differences in patients with COVID-19: Focus on severity and mortality. Front. Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Barek M.A., Aziz M.A., Islam M.S. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6:e05684. doi: 10.1016/j.heliyon.2020.e05684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05684</ArticleId><ArticleId IdType="pmc">PMC7737518</ArticleId><ArticleId IdType="pubmed">33344791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J., Li Q., Jiang C., Zhou Y., Liu S., et al. Risk factors of critical and mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 2020;81:e16&#x2013;e25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu A.K., Mathew R., Aggarwal P., Nayer J., Bhoi S., Satapathy S., Ekka M. Clinical determinants of severe COVID-19 Disease: A systematic review and meta-analysis. J. Glob. Infect. Dis. 2021;13:13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054797</ArticleId><ArticleId IdType="pubmed">33911447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha J., Qie G., Yao Q., Sun W., Wang C., Zhang Z., Wang X., Wang P., Jian J., Bai X., et al. Sex differences on clinical characteristics, severity, and mortality in adult patients with COVID-19: A multicentre retrospective study. Front. Med. 2021;8:607059. doi: 10.3389/fmed.2021.607059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.607059</ArticleId><ArticleId IdType="pmc">PMC7906985</ArticleId><ArticleId IdType="pubmed">33644092</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T., Deeks J.J., Dinnes J., Takwoingi Y., Davenport C., Leeflang M.M., Spijker R., Hooft L., Emperador D., Dittrich S., et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst. Rev. 2020;7:CD013665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386785</ArticleId><ArticleId IdType="pubmed">32633856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K., Montenegro-Jim&#xe9;nez Y., Torres-Castro R., Vera-Uribe R., Torralba Y., Alsina-Restoy X., Vasconcello-Castillo L., Vilar&#xf3; J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron. Respir. Dis. 2021;18:14799731211002240. doi: 10.1177/14799731211002240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden: What is Long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study. medRxiv. 2021 doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xc1; Steig B., Gaini S., Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands&#x2014;A longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic. Clin. Infect. Dis. 2021;73:e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Capdevila Pujol J., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Barrett K.M.S., Riffle S., Bolze A., Neveux I., Dabe S., Grzymski J.J., Lu J.T., Washington N.L. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020 doi: 10.1101/2020.10.07.20208702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Green J., Santillana M.H., Lazer D., Ognyanova K., Simonson M., Baum M.A., Quintana A., Chwe H., Druckman J., et al. Persistence of symptoms up to 10 months following acute COVID-19 illness. medRxiv. 2021 doi: 10.1101/2021.03.07.21253072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.07.21253072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long COVID in adults discharged from UK hospitals after COVID-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nikita Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang Z., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J., Navarro-Pardo E., Torres-Macho J., Canto-Diez M.G., Pellicer-Valero O. Gastrointestinal symptoms at the acute COVID-19 phase are risk factors for developing gastrointestinal post-COVID symptoms: A multicenter study. Intern. Emerg. Med. 2021:1&#x2013;4. doi: 10.1007/s11739-021-02850-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02850-5</ArticleId><ArticleId IdType="pmc">PMC8505473</ArticleId><ArticleId IdType="pubmed">34637081</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Pellicer-Valero O.J., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Mart&#xed;n-Guerrero J.D., Cigar&#xe1;n-M&#xe9;ndez M. The number of symptoms at the acute COVID-19 phase is associated with anxiety and depressive long-term post-COVID symptoms: A multicenter study. J. Psychosom. Res. 2021;150:110625. doi: 10.1016/j.jpsychores.2021.110625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110625</ArticleId><ArticleId IdType="pmc">PMC8455234</ArticleId><ArticleId IdType="pubmed">34563747</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Navarro-Pardo E., Fuensalida-Novo S., Palacios-Ce&#xf1;a M., Velasco-Arribas M., Pellicer-Valero O.J. The presence of rheumatological conditions is not a risk factor of long-term post-COVID symptoms after SARS-CoV-2 infection: A multicenter study. Clin. Rheumatol. 2021:1&#x2013;2. doi: 10.1007/s10067-021-05935-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05935-w</ArticleId><ArticleId IdType="pmc">PMC8475301</ArticleId><ArticleId IdType="pubmed">34561811</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedman E., Lj&#xf3;tsson B., Blom K., El Alaoui S., Kraepelien M., R&#xfc;ck C., Andersson G., Svanborg C., Lindefors N., Kaldo V. Telephone versus internet administration of self-report measures of social anxiety, depressive symptoms, and insomnia: Psychometric evaluation of a method to reduce the impact of missing data. J. Med. Internet Res. 2013;15:e229. doi: 10.2196/jmir.2818.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.2818</ArticleId><ArticleId IdType="pmc">PMC3806436</ArticleId><ArticleId IdType="pubmed">24140566</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann-Lingen C., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale&#x2013;Deutsche Version (HADS-D) Verlag Hans Huber; Bern, Switzerland: 2011.</Citation></Reference><Reference><Citation>Olss&#xf8;n I., Mykletun A., Dahl A.A. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46. doi: 10.1186/1471-244X-5-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-5-46</ArticleId><ArticleId IdType="pmc">PMC1343544</ArticleId><ArticleId IdType="pubmed">16351733</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupo de Trabajo de la Gu&#xed;a de Pr&#xe1;ctica Cl&#xed;nica para el Manejo de Pacientes con Trastornos de Ansiedad en Atenci&#xf3;n Primaria 2008 . Gu&#xed;as de Pr&#xe1;ctica Cl&#xed;nica en el SNS-UETS N&#xba; 2006/10. Unidad de Evaluaci&#xf3;n de Tecnolog&#xed;as Sanitarias, Agencia La&#xed;n Entralgo, Comunidad de Madrid; Madrid, Spain: 2008. Plan Nacional para el SNS del MSC.</Citation></Reference><Reference><Citation>Deng J., Zhou F., Hou W., Silver Z., Wong C.Y., Chang C., Huang E., Zuo Q.K. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: A meta-analysis. Ann. N. Y. Acad. Sci. 2021;1486:90&#x2013;111. doi: 10.1111/nyas.14506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14506</ArticleId><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter J.S., Andrykowski M.A. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J. Psychosom. Res. 1998;45:5&#x2013;13. doi: 10.1016/S0022-3999(97)00298-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(97)00298-5</ArticleId><ArticleId IdType="pubmed">9720850</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentr&#xe9; F., Bachelet D., Laou&#xe9;nan C., French COVID cohort study and investigators groups Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: Results from a large prospective cohort. Clin. Microbiol. Infect. 2021;27:1041. doi: 10.1016/j.cmi.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F., Bairey Merz N., Barnes P.J., Brinton R.D., Carrero J.J., DeMeo D.L., De Vries G.J., Epperson C.N., Govindan R., Klein S.L., et al. Sex and gender: Modifiers of health, disease, and medicine. Lancet. 2020;396:565&#x2013;582. doi: 10.1016/S0140-6736(20)31561-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31561-0</ArticleId><ArticleId IdType="pmc">PMC7440877</ArticleId><ArticleId IdType="pubmed">32828189</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020;11:29. doi: 10.1186/s13293-020-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of adults with non-critical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Aebischer Perone S., Courvoisier D., Chappuis F., Guessous I., COVICARE TEAM COVID-19 Symptoms: Longitudinal evolution and persistence in outpatient settings. Ann. Intern. Med. 2020;172:M20-5926. doi: 10.7326/M20-5926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Rein Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:005422020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Torres-Macho J., Velasco-Arribas M., Arias-Naval&#xf3;n J.A., Guijarro C., Hern&#xe1;ndez-Barrera V., Canto-Diez M.G. Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study. J. Infect. 2021;83:237&#x2013;279. doi: 10.1016/j.jinf.2021.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.034</ArticleId><ArticleId IdType="pmc">PMC8089027</ArticleId><ArticleId IdType="pubmed">33957161</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Pachon E., Grau-Delgado J., Soler-Sempere M.J., Zamora-Molina L., Baeza-Martinez C., Ruiz-Alcaraz S., Padilla-Navas I. Low prevalence of post-COVID-19 syndrome in patients with asthma. J. Infect. 2021;82:276&#x2013;316. doi: 10.1016/j.jinf.2021.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.03.023</ArticleId><ArticleId IdType="pmc">PMC8017946</ArticleId><ArticleId IdType="pubmed">33819552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire G.M. Coronavirus: Why men are more vulnerable to COVID-19 than women? SN Compr. Clin. Med. 2020;2:874&#x2013;876. doi: 10.1007/s42399-020-00341-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Buonsenso D., Carfi A., Malorni W., Long COVID Kids study group Long COVID: An estrogen-associated autoimmune disease? Cell Death Discov. 2021;7:77. doi: 10.1038/s41420-021-00464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Anca P.S., Toth P.P., Kempler P., Rizzo M. Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int. J. Clin. Pract. 2021;75:e13666. doi: 10.1111/ijcp.13666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13666</ArticleId><ArticleId IdType="pmc">PMC7435574</ArticleId><ArticleId IdType="pubmed">32770758</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N., Hosseinian-Far A., Jalali R., Vaisi-Raygani A., Rasoulpoor S., Mohammadi M., Rasoulpoor S., Khaledi-Paveh B. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and meta-analysis. Glob. Health. 2020;16:57. doi: 10.1186/s12992-020-00589-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-020-00589-w</ArticleId><ArticleId IdType="pmc">PMC7338126</ArticleId><ArticleId IdType="pubmed">32631403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>